Overview
Prerenal acute kidney injury (AKI) occurs due to decreased renal perfusion, often resulting from hypovolemia, which can be absolute (dehydration, hemorrhage) or relative (vasodilation). It is characterized by elevated serum creatinine and urea levels secondary to impaired glomerular filtration rate (GFR). 124Diagnosis
Clinical signs: Oliguria, elevated BUN and creatinine levels.
Laboratory tests: Urinalysis showing concentrated appearance, fractional excretion of sodium (FENa) often <1%.
Imaging: Renal ultrasound typically normal unless other etiologies coexist.
Fluid status assessment: Monitoring hemodynamic parameters like blood pressure, heart rate, and central venous pressure. 25Management
Fluid resuscitation: Initial treatment involves rapid intravenous fluid administration (crystalloids or colloids) to restore intravascular volume. 25
Blood transfusion: In cases of significant hemorrhage, appropriate blood product transfusion to correct anemia and maintain hemodynamic stability. 2
Control of hypotension: Use of vasopressors like intravenous nitroglycerin to manage hypotension cautiously, aiming MAP at 65-75 mmHg to balance perfusion and renal protection. 2
Monitoring: Continuous monitoring of renal function, systemic oxygen metabolism, and hemodynamic parameters to guide fluid and vasopressor therapy adjustments. 24Special Populations
Elderly: Careful fluid management with restrictive transfusion strategies may help reduce intraoperative blood loss and maintain renal function, though close monitoring is essential. 2
Comorbidities: Patients with sepsis or heat stress require vigilant management of relative hypovolemia to prevent further splanchnic hypoperfusion and organ dysfunction. 4Key Recommendations
Initiate rapid fluid resuscitation with crystalloids or colloids to address hypovolemia in prerenal AKI (Evidence: Strong 25).
Target mean arterial pressure (MAP) between 65-75 mmHg using controlled hypotension and restrictive transfusion strategies in elderly patients to minimize blood loss and preserve renal function (Evidence: Moderate 2).
Monitor systemic oxygen metabolism and renal function closely during fluid and vasopressor therapy adjustments (Evidence: Moderate 24).
Consider pharmacologic blockade of sympathetic and renin-angiotensin systems in severe cases to mitigate mesenteric hypoperfusion and preserve intestinal mucosal function (Evidence: Weak 4).References
1 Kimball JP, Inan OT, Convertino VA, Cardin S, Sawka MN. Wearable Sensors and Machine Learning for Hypovolemia Problems in Occupational, Military and Sports Medicine: Physiological Basis, Hardware and Algorithms. Sensors (Basel, Switzerland) 2022. link
2 Qiu X, Tan Z, Tang W, Ye H, Lu X. Effects of controlled hypotension with restrictive transfusion on intraoperative blood loss and systemic oxygen metabolism in elderly patients who underwent lumbar fusion. Trials 2021. link
3 Mansoor Baig M, Gholamhosseini H, Harrison MJ. Fuzzy logic based anaesthesia monitoring systems for the detection of absolute hypovolaemia. Computers in biology and medicine 2013. link
4 Aneman A, Pettersson A, Eisenhofer G, Friberg P, Holm M, von Bothmer C et al.. Sympathetic and renin-angiotensin activation during graded hypovolemia in pigs: impact on mesenteric perfusion and duodenal mucosal function. Shock (Augusta, Ga.) 1997. link
5 Mythen MG, Salmon JB, Webb AR. The rational administration of colloids. Blood reviews 1993. link90009-s)
6 Farjam A, Vreuls JJ, Cuppen WJ, Brinkman UA, de Jong GJ. Direct introduction of large-volume urine samples into an on-line immunoaffinity sample pretreatment-capillary gas chromatography system. Analytical chemistry 1991. link